How do lymphocytes kill tumor cells?
نویسندگان
چکیده
837 Phase II Study of Docetaxel in Patients with Epithelial Ovarian Carcinoma Refractory to Platinum. John J. Kavanagh. Andrzej P. Kudelka, Cesar Gonzalez de Leon, Damrong Tresukosol. Mary Hord, M. Beth Finnegan, E. Edmund Kim, Datla Varma, Arthur Forman, Paul Cohen, Creighton L. Edwards, Ralph S. Freedman, and Claire F. Verschraegen. 855 Differential Induction of Apoptosis by all-trans-Retinoic Acid and N-(4-Hydroxyphenyl)retinamide in Human Head and Neck Squamous Cell Carcinoma Cell Lines. Nobuhiko Oridate. Dafna Lotan, Xiao-Chun Xu, Waun K. Hong, and Reuben Lotan.
منابع مشابه
In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor
Although the immune system evolved to fight infections, it may also attack and destroy solid tumors. In most cases, tumor rejection is initiated by CD8(+) cytotoxic T lymphocytes (CTLs), which infiltrate solid tumors, recognize tumor antigens, and kill tumor cells. We use a combination of two-photon intravital microscopy and immunofluorescence on ordered sequential sections to analyze the infil...
متن کاملImmunohistochemical evaluation of lymphocyte types infiltrate into the canine seminomas
BACKGROUNDS: Seminoma is frequently observed in human and canine testes especially in cryptorchids. Canine and human seminomas are typically associated with leukocytic infiltration. OBJECTIVES: We aimed to identify the type of lymphocytes that infiltrate to seminomas. METHODS: Tumor infiltrating lymphocytes were evaluated by immunohistological techniques in 5 dogs with diffuse seminoma. Routine...
متن کاملCytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide.
Heteroclitic peptide modifications increase immunogenicity, allowing generation of cytotoxic T lymphocytes (CTLs) against weakly immunogenic tumor-associated antigens (TAAs). A critical issue is whether T cells generated against heteroclitic peptides retain the ability to recognize and kill tumor cells expressing the original weak TAAs, and whether there is a lower threshold of binding affinity...
متن کاملNK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors.
Natural killer (NK) cells are generally reported as innate effector cells for killing virally infected and transformed cells. It is unclear how NK cells evoke adaptive immunity to eradicate tumors. We now demonstrate that the TNF superfamily member, LIGHT, known as TNFSF14 and a T-cell costimulatory molecule, is a critical ligand for the activation of NK cells. Herpesvirus entry mediator (HVEM)...
متن کاملHow Do Cytotoxic Lymphocytes Kill Cancer Cells?
In the past few years, cancer immunotherapy has emerged as a safe and effective alternative for treatment of cancers that do not respond to classical treatments, including those types with high aggressiveness. New immune modulators, such as cytokines, blockers of CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) and PD-1(programmed cell death protein 1)/PD-L1 (programmed death-ligand 1), and...
متن کاملDecay Dynamics of Tumors
The fractional cell kill is a mathematical expression describing the rate at which a certain population of cells is reduced to a fraction of itself. We investigate the mathematical function that governs the rate at which a solid tumor is lysed by a cell population of cytotoxic lymphocytes. We do it in the context of enzyme kinetics, using geometrical and analytical arguments. We derive the equa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical cancer research : an official journal of the American Association for Cancer Research
دوره 2 5 شماره
صفحات -
تاریخ انتشار 1996